SynthesisJCO clinical cancer informatics2025
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study.
Yasuaki Sagara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.